A bipartisan group of state attorneys general is asking the U.S. Food and Drug Administration for a progress report on the fight against opioids.
In a letter to FDA Commissioner Stephen Hahn, the attorneys general seek information about what the FDA has done under the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (“SUPPORT Act”) to fight the opioid epidemic, as well as what the agencies future steps are.
“While combatting COVID-19 has, understandably, been at the forefront of conversations about health and safety during these last 10 months, we cannot lose sight of the fact that the drug crisis continues to take the lives of Kentuckians,” said Kentucky Attorney General Daniel Cameron. “The FDA plays a critical role in combatting this crisis, and I, and my colleagues in other states, joined together in sending this letter to request an update on the agency’s progress and next steps.”
Provisions of the act give the FDA new powers, including implementing safer opioid packaging and disposal features, handling research and issuing new regulations on non-addictive alternatives to opioids, and presenting guidelines for opioid prescribing.